Advertisement
Advertisement
U.S. markets open in 4 hours 40 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Accolade, Inc. (ACCD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
8.83+0.63 (+7.68%)
At close: 04:00PM EST
8.83 -0.00 (-0.01%)
After hours: 04:47PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close8.20
Open8.25
Bid0.00 x 1400
Ask0.00 x 800
Day's Range8.07 - 8.89
52 Week Range4.61 - 27.74
Volume1,033,664
Avg. Volume651,647
Market Cap635.22M
Beta (5Y Monthly)1.48
PE Ratio (TTM)N/A
EPS (TTM)-1.93
Earnings DateJan 09, 2023 - Jan 13, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est13.93
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ACCD

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Accolade, Inc.
    Daily – Vickers Top Buyers & Sellers for 06/16/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    6 months agoArgus Research
View more
  • PR Newswire

    Accolade Champions Health Equity and Welcomes FOLX Health to Trusted Partner Ecosystem at HLTH 2022

    Accolade, Inc. (Nasdaq: ACCD), which provides millions of people and their families with Personalized Healthcare, will address removing barriers to equitable healthcare as a Health Equity Impact Champion sponsor at HLTH 2022. In addition, LGBTQIA+ affirming care company, FOLX Health, joins Accolade's Trusted Partner Ecosystem, availing high-quality, integrated care for this marginalized population to Accolade 's 700+ commercial and government customers to serve their 11 million members.

  • Simply Wall St.

    Accolade (NASDAQ:ACCD) investors are sitting on a loss of 70% if they invested a year ago

    While it may not be enough for some shareholders, we think it is good to see the Accolade, Inc. ( NASDAQ:ACCD ) share...

  • Benzinga

    Accolade Posts Narrower Quarterly Loss, Tightens Annual Sales Guidance

    Accolade Inc (NASDAQ: ACCD) reported Q2 FY23 sales of $87.6 million, up 20% Y/Y, beating the consensus of $82.86 million and the management guidance of $82-$83.5 million. "Importantly, this is also our first full year selling our broader integrated services, and we are receiving strong validation from both new and current customers that our integrated portfolio is the right approach," said Rajeev Singh, Accolade CEO. The adjusted EBITDA loss came at $(13.7) million, better than $(19.4) million a

Advertisement
Advertisement